Abstract:Background Pregabalin is a gamma-aminobutyric acid (GABA) analog that was approved in the EU in 2004 for the treatment of neuropathic pain, generalized anxiety disorder and epilepsy. Since its introduction, pregabalin abuse and misuse has increased significantly. In Switzerland, clinical reports suggest that pregabalin misuse is common among patients in forensic hospitals and prisons. However, data on pregabalin use is scarce, especially in these settings. Therefore, we conducted a study to explore patterns of pregabalin use among prison and forensic patients. Methods We used a questionnaire to survey physicians working in prison and forensic medicine in German-speaking countries. A total of 131 responses were received. Results According to the physicians' subjective assessment, 82.5% of them had observed a recent increase in pregabalin use by their patients and 89.1% of them reported that their patients requested pregabalin without a clear medical indication. Patients misusing pregabalin in combination with other illicit substances were observed by 93.3% of the physicians surveyed. According to 73.5% of the physicians surveyed, they had already encountered patients on pregabalin doses of more than 600 mg/day (the maximum recommended daily dose); the highest dose reported was 4,200 mg/day. According to 85.0% of physicians surveyed, they have observed patients experiencing withdrawal symptoms from pregabalin, with the most commonly reported symptoms being displeasure and high aggression. Regarding the nationality of pregabalin-misusing patients, 58.3% of the interviewed physicians reported to be rather in contact with foreign patients, mainly from Northwest Africa (Maghreb). Only 45.0% of the surveyed physicians prescribe pregabalin. Among patients who developed behavioral problems while taking pregabalin, none of the physicians (0.0%) showed a tendency to continue pregabalin at the same dose; all respondents chose to reduce/substitute/discontinue. Conclusion Our study has provided confirmatory evidence that the use of pregabalin presents a significant issue in forensic and prison medicine across German-speaking countries. Prescribing pregabalin in this field can compound use disorder problems and exacerbate challenges in daily life for those in forensic institutions or prisons. It is necessary that all physicians who prescribe pregabalin are clearly informed about the management (including the risks) of this drug.

Trends in Pregabalin Use and Prescribing Patterns in the Adult Population: A 10-Year Pharmacoepidemiologic Study

Characteristics of Non-Therapeutic Pregabalin Users Detected by a Community Pharmacies Network in a Region of Southern Europe

Trends in gabapentinoid prescribing in UK primary care using the Clinical Practice Research Datalink: an observational study

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Pregabalin for Postherpetic Neuralgia in A Population of Chinese Patients

Pregabalin use in forensic hospitals and prisons in German speaking countries—a survey study of physicians

Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend study

Trends of Anti-Seizure Medication Use in Pediatric Patients in Six Cities in China from 2013 to 2018

Pregabalin and gabapentin abuse among university students in Jordan: A cross sectional study

Anti-seizure Medication Prescription in Adult Outpatients with Epilepsy in China, 2013–2018

A meta-epidemiological study on the reported treatment effect of pregabalin in neuropathic pain trials over time

Gabapentinoid prescribing patterns and predictors utilizing neural networks: An analysis across emergency departments Nationwide between 2012 and 2021

Secular trends in gabapentinoid dispensing by compensated workers with low back pain: a retrospective cohort study

A systematic review of the effectiveness of policies restricting access to pregabalin

Risk of adverse outcomes during gabapentinoid therapy and factors associated with increased risk in UK primary care using the clinical practice research datalink: a cohort study

Trends in prescribing patterns of antiepileptic drugs among older adult inpatients in a Brazilian tertiary center

Update to Gabapentinoid Use in the United States, 2002-2021

Signal detection of adverse events associated with gabapentinoid use for chronic pain

Opioid trends and risk factors for sustained use among children and adolescents in Israel: a retrospective cohort study

Reasons for use and experiences of using phenibut, a mixed methods analysis of online reports

Experiences of misuse and symptoms of dependence among people who use gabapentinoids: A qualitative systematic review

Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials